Trastuzumab and breast cancer
Rudlowski, C.; Rath, W.; Becker, A.J.; Wiestler, O.D.; Buttner, R.
New England Journal of Medicine 345(13): 997-998
2001
ISSN/ISBN: 0028-4793 PMID: 11575298 Document Number: 535634
Document emailed within 1 workday
Related Documents
Altundag, K. 2017: Predictive markers for trastuzumab-associated cardiac dysfunction in patients with early-stage human epidermal growth factor receptor 2-positive breast cancer receiving trastuzumab Journal of BUON: Official Journal of the Balkan Union of Oncology 22(3): 801Murphy, C.G.; Fornier, M. 2010: HER2-positive breast cancer: beyond trastuzumab Oncology 24(5): 410-415
Nicol, M.; Baudet, M.; Cohen Solal, A. 2018: Acute dyspnea after trastuzumab-treated breast cancer La Revue du Praticien 68(3): 303-306
Heinzl, S. 2000: Trastuzumab. Monoclonal antibody for the treatment of breast cancer Medizinische Monatsschrift für Pharmazeuten 23(11): 350-352
Tahover, E.; Sonnenblick, A.; Peretz, T.; Katz, D. 2012: Update: adjuvant trastuzumab in HER2 positive breast cancer Harefuah 151(1): 37-42 61
Wang, Y.; Li, J-jie.; Di, G-hong.; Lu, J-song.; Wu, J.; Liu, G-yu.; Hu, X-chun.; Wang, Z-hua.; Yang, W-tao.; Shao, Z-min. 2010: Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer Zhonghua Zhong Liu Za Zhi 32(11): 864-867
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Christodoulou, C.; Klouvas, G.; Pateli, A.; Mellou, S.; Sgouros, J.; Skarlos, D.V. 2003: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer Anticancer Research 23(1b): 737-744
Hirano, T.; Sakurai, K.; Fujisaki, S.; Maeda, T.; Nagashima, S.; Hara, Y.; Tomita, R.; Suzuki, S.; Enomoto, K.; Amano, S. 2012: Lapatinib is useful for metastatic breast cancer patients who cannot be treated with trastuzumab-report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2045-2047
Hayashi, M.; Orita, M.; Hironaka, H.; Morita, N. 2014: A case of trastuzumab-resistant breast cancer responding to lapatinib/capecitabine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(3): 353-355
Rai, Y.; Sagara, Y.; Sagara, Y.; Takahama, T.; Matsuyama, Y.; Ando, M.; Sagara, Y.; Ooi, Y.; Inoue, K.; Kurosumi, M. 2007: Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(1): 65-68
Yoshida, T.; Horiguchi, J.; Koibuchi, Y.; Kanoh, T.; Iijima, K.; Yoshida, M.; Kikuchi, M.; Takata, D.; Oyama, T.; Iino, Y.; Morishita, Y. 2004: Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 907-910
Matsuoka, A.; Inoue, H.; Ogura, K.; Hattori, A.; Yukawa, H.; Sakaguchi, S.; Tanaka, N.; Kodera, A.; Kamimura, M.; Naritaka, Y.; Hirano, A. 2018: HER2-Positive Breast Cancer with Severe Infusion Reaction to Pertuzumab plus Trastuzumab-A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 1863-1865
Nagahisa, Y.; Imai, S.; Yamaguchi, K.; Okabe, M.; Tsuruta, A.; Kawamoto, K.; Niwano, M.; Sano, K.; Park, T.; Yoshida, Y.; Ito, T.; Ogasahara, K. 2007: A case of liver metastasis of breast cancer responding to trastuzumab plus weekly paclitaxel chemotherapy maintaining CR for 30 months Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(9): 1501-1503
Ishida, K. 2013: A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1385-1387
Matsuda, T.; Fujita, H.; Kunimoto, Y.; Hosono, M.; Kimura, T.; Hayashi, T.; Maeda, T.; Yamakawa, J.; Maeda, N.; Mizumoto, T.; Maruyama, S.; Uenaka, Y.; Ogino, K. 2013: Successful ventilator weaning by trastuzumab in a HER2-positive breast cancer patient with multiple lung metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(6): 773-776
Di Lauro, V.; Murrone, A.; Bidoli, E.; Magri, M.D.; Crivellari, D.; Veronesi, A. 2008: Trastuzumab and vinorelbine as highly effective and safe therapy for HER-2-overexpressing metastatic breast cancer. A single institution experience Tumori 94(4): 464-468
Ohsako, T.; Inoue, K.; Nagamoto, N.; Yoshida, Y.; Nakahara, O. 2006: Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(9): 1301-1303
Hashimoto, K.; Nio, Y.; Koike, M.; Itakura, M.; Yano, S.; Higami, T. 2004: A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1391-1393
Kimura, M.; Sano, M.; Tabei, T.; Asaga, T.; Ando, J.; Fujii, H.; Yamamoto, N.; Kurosumi, M. 2005: Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 335-339